Instylla

United States Founded: 2017 • Age: 9 yrs
Hydrogel technology is developed for embolization therapy applications.
Request Access

About Instylla

Instylla is a company based in United States founded in 2017. It operates as a HealthTech. Instylla has raised $85.51 million across 4 funding rounds from investors including Delos Capital, Excelestar Ventures and Ascension Ventures. The company has 26 employees as of December 31, 2020. Instylla offers products and services including Embrace Hydrogel Embolic System and Tembo Embolic System.

  • Headquarter United States
  • Employees 26 as on 31 Dec, 2020
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Instylla, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $85.51 M (USD)

    in 4 rounds

  • Latest Funding Round
    $21.73 M (USD), Series B

    Jul 07, 2025

  • Investors
  • Employee Count
    26

    as on Dec 31, 2020

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Instylla

Instylla offers a comprehensive portfolio of products and services, including Embrace Hydrogel Embolic System and Tembo Embolic System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Used for embolization of hypervascular peripheral tumors.

Designed for embolization in interventional radiology applications.

People of Instylla
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Kathryn McCarthy
Manufacturing Engineer
People
Joan B.
Clinical Research Associate III
People
Stephanie Cavoores
Senior Clinical Field Manager
People
Sarala Vallabhaneni
Clinical Research Associate II

Unlock access to complete

Funding Insights of Instylla

Instylla has successfully raised a total of $85.51M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $21.73 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series B — $21.7M
  • First Round

    (06 Jun 2017)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2025 Amount Series B - Instylla Valuation

investors

Aug, 2023 Amount Series B - Instylla Valuation Delos Capital
Oct, 2020 Amount Series B - Instylla Valuation Excelestar Ventures , Sparta Group
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Instylla

Instylla has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Delos Capital, Excelestar Ventures and Ascension Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Delos Capital is engaged in private equity and financial advisory services.
Founded Year Domain Location
Late stage tech-focused VC firm funding companies in the US
Founded Year Domain Location
Strategic investments in healthcare technologies and data innovations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Instylla

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Instylla

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Instylla Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Instylla

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Instylla

Frequently Asked Questions about Instylla

When was Instylla founded?

Instylla was founded in 2017.

Where is Instylla located?

Instylla is headquartered in United States.

Is Instylla a funded company?

Instylla is a funded company, having raised a total of $85.51M across 4 funding rounds to date. The company's 1st funding round was a Series B of $25.43M, raised on Jun 06, 2017.

How many employees does Instylla have?

As of Dec 31, 2020, the latest employee count at Instylla is 26.

What does Instylla do?

Instylla is focused on the development of next-generation liquid embolics for interventional radiology. Applications are primarily targeted at interventional oncology and peripheral hemostasis. Solutions like Embrace Hydrogel Embolic System are designed for embolization of hypervascular tumors in peripheral arteries. The company aims to advance medical procedures through innovative embolic systems.

What products or services does Instylla offer?

Instylla offers Embrace Hydrogel Embolic System and Tembo Embolic System.

Who are Instylla's investors?

Instylla has 8 investors. Key investors include Delos Capital, Excelestar Ventures, Ascension Ventures, CHV, and AMED Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available